Diagnostic Utility of Genetic Testing in Hyperthyroxinemia With Non‐Suppressed TSH
Clinical Endocrinology · 2026-06 · 104 (6) · 693-701
DOI: 10.1111/cen.70126 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Clinical Endocrinology, online erschienen am 09.03.2026. Verfasst von Hilal Sekizkardes und 5 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Endocrinology, Department of Pediatrics, Sancaktepe Sehit Prof Dr Ilhan Varank Training and Research Hospital, Istanbul, Turkey. Hauptthemen laut MEDLINE: Thyrotropin, Hyperthyroxinemia, Genetic Testing. Die Arbeit nennt 29 Literaturangaben.
Abstract (Originalsprache)
Background
Hyperthyroxinemia with non‐suppressed thyroid‐stimulating hormone (TSH) is a complex clinical entity that presents significant diagnostic challenges. Inherited causes include resistance to thyroid hormone beta (RTHβ), characterised by highly variable clinical presentation, and familial dysalbuminemic hyperthyroxinemia (FDH), a form of assay interference caused by pathogenic variants in the ALB gene leading to pseudo elevation of free thyroxine (FT4). This study aimed to characterise the clinical, laboratory, and molecular features of a paediatric cohort presenting with hyperthyroxinemia and non‐suppressed TSH, and to identify clinical parameters that may aid in differential diagnosis.
Methods
In this retrospective observational study, 25 children from 19 unrelated families with elevated FT4 and non‐suppressed TSH were evaluated. Clinical history, anthropometric data, physical examination findings, vital signs, laboratory results, radiological imaging, and sequencing data of the THRB and/or ALB genes were reviewed.
Results
THRB gene sequencing was performed in 21 children from 18 families, identifying pathogenic or likely pathogenic variants in six patients from six unrelated families, including a novel variant c.997 G > C, p.(Glu333Gln), consistent with a diagnosis of RTHβ in 33.3% of those tested. Among these patients, tachycardia was observed in three cases (50%). ALB gene sequencing was completed in 16 children from 13 families, revealing the hotspot variant c.725 G > A, p.(Arg242His) in 12 patients from six unrelated families, corresponding to FDH in 46.2% of those tested. None of the FDH‐confirmed patients exhibited tachycardia or other signs of thyroid dysfunction. FT4 and TSH levels were similar between RTHβ and FDH groups; however, FT3 levels tended to be lower in FDH, although FT3/FT4 ratio did not differ significantly.
Conclusion
Our findings highlight the critical role of molecular testing in accurately diagnosing the underlying cause of elevated FT4 with non‐suppressed TSH and in preventing unnecessary interventions. Hotspot analysis of the ALB gene is recommended as a first‐line test, particularly in asymptomatic individuals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pediatric Endocrinology, Department of Pediatrics, Sancaktepe Sehit Prof Dr Ilhan Varank Training and Research Hospital, Istanbul, Turkey.
- Department of Medical Genetics, Van Training and Research Hospital, University of Health Sciences, Van, Turkey.
- Pediatric Cardiology, Department of Pediatrics, Sancaktepe Sehit Prof Dr Ilhan Varank Training and Research Hospital, Istanbul, Turkey.
- Pediatric Endocrinology and Diabetes, Department of Pediatrics, School of Medicine, Marmara University, Istanbul, Turkey.
- Pediatric Endocrinology, Department of Pediatrics, School of Medicine, Acibadem Mehmet Ali Aydinlar University, Istanbul, Turkey.
ORCID-Profile: Hilal Sekizkardes, Mehmet Eltan, Senol Demir, Dilek Giray, Zehra Yavas Abali, Saygin Abali
Zitieren
APA
Sekizkardes, H., Eltan, M., Demir, S., Giray, D., Yavas Abali, Z., & Abali, S. (2026). Diagnostic Utility of Genetic Testing in Hyperthyroxinemia With Non‐Suppressed TSH. Clinical Endocrinology, 104(6), 693-701. https://doi.org/10.1111/cen.70126
Vancouver
Sekizkardes H, Eltan M, Demir S, Giray D, Yavas Abali Z, Abali S. Diagnostic Utility of Genetic Testing in Hyperthyroxinemia With Non‐Suppressed TSH. Clinical Endocrinology. 2026;104(6):693-701. doi:10.1111/cen.70126
BibTeX
@article{Sekizkardes2026,
author = {Sekizkardes, Hilal and Eltan, Mehmet and Demir, Senol and Giray, Dilek and Yavas Abali, Zehra and Abali, Saygin},
title = {Diagnostic Utility of Genetic Testing in Hyperthyroxinemia With Non‐Suppressed TSH},
journal = {Clinical Endocrinology},
year = {2026},
volume = {104},
number = {6},
pages = {693--701},
doi = {10.1111/cen.70126}
}
EUVIMED